Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.
- DOI
- 10.1038/s41541-025-01355-y
- Published
- 2026-01-17
- Container
- NPJ Vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41541-025-01355-y,
title = {Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.},
author = {Earnest L and Ruiz DF and Edeling MA and Montoya JC and Yap AHY and Wong CY and Holz LE and Gras S and Collett S and Cooney JP and Davidson KC and Grimley SL and Purcell DFJ and Roberts J and Mumford J and Tan CW and Wang LF and Godfrey DI and Frieman M and Hans D and Vincan E and Anderson DE and Subbarao K and Pellegrini M and Mackenzie JM and Rockman S and Heath WR and Torresi J.},
year = {2026},
journal = {NPJ Vaccines},
doi = {10.1038/s41541-025-01355-y},
url = {https://doi.org/10.1038/s41541-025-01355-y}
}RIS
TY - JOUR TI - Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59. AU - Earnest L AU - Ruiz DF AU - Edeling MA AU - Montoya JC AU - Yap AHY AU - Wong CY AU - Holz LE AU - Gras S AU - Collett S AU - Cooney JP AU - Davidson KC AU - Grimley SL AU - Purcell DFJ AU - Roberts J AU - Mumford J AU - Tan CW AU - Wang LF AU - Godfrey DI AU - Frieman M AU - Hans D AU - Vincan E AU - Anderson DE AU - Subbarao K AU - Pellegrini M AU - Mackenzie JM AU - Rockman S AU - Heath WR AU - Torresi J. PY - 2026 JO - NPJ Vaccines DO - 10.1038/s41541-025-01355-y UR - https://doi.org/10.1038/s41541-025-01355-y ER -
APA
L, E., DF, R., MA, E., JC, M., AHY, Y., CY, W., LE, H., S, G., S, C., JP, C., KC, D., SL, G., DFJ, P., J, R., J, M., CW, T., LF, W., DI, G., M, F., D, H., E, V., DE, A., K, S., M, P., JM, M., S, R., WR, H., & J., T. (2026). Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.. NPJ Vaccines. https://doi.org/10.1038/s41541-025-01355-y
Source records
- europe-pmc · retrieved 2026-09-25T15:24:12.040Z
- doaj · retrieved 2026-09-25T15:24:12.022Z